Subscribe to News
News  |  Fundraising

Ramaciotti Foundation Medal Announced

Monday, 23rd November 2009 at 4:29 pm
Staff Reporter
Breakthrough malaria researcher Professor Geoff McFadden wins Ramaciotti Medal

Monday, 23rd November 2009
at 4:29 pm
Staff Reporter



Ramaciotti Foundation Medal Announced
Monday, 23rd November 2009 at 4:29 pm

One of the largest private contributors to biomedical research in Australia, the Ramaciotti Foundation has awarded its prestigious Ramaciotti Medal for Excellence in Biomedical Research to a scientist who made a major breakthrough in treating a disease responsible for over 1 million deaths each year.


The medal was presented to Melbourne University’s Professor Geoff McFadden , at the annual Ramaciotti Awards, where Perpetual will distribute $2.5 million in funding to Australian biomedical researchers. The Ramaciotti medal carries an award of $50,000.


Prof. McFadden’s research has provided a basis for developing new ways to combat one of the world’s major health problems, malaria. The malaria parasite infects more than 300 million people each year, killing around 1 million of them, who are mostly small children.


In his research, Prof. McFadden co-discovered a plant-like structure known as a ‘chloroplast’ in the parasite that causes malaria. Leading a team of 12 scientists including postdoctoral fellows, PhD students, research assistants and undergraduate students, his subsequent research has focused on why the parasite has a relict structure in common with plants.


Either there are no banners, they are disabled or none qualified for this location!

Professor McFadden says winning the Ramaciotti Medal is a great honour and the grant will help to pay researchers, provide state-of-the-art facilities and give them the chance to remain internationally competitive and at the cutting edge of our field.


The Ramaciotti Medal  recognises outstanding contribution to clinical or biomedical research, or the way in which healthcare is delivered. 


David Knowles, National Manager of Perpetual’s Philanthropic Services, which manages the charitable trust, says that the Ramaciotti Medal is an important way to promote Australians engaged in world leading biomedical research.


“There are so many passionate and committed biomedical researchers working to improve our health, beat diseases and create better treatments, yet funding is limited. The Ramaciotti Foundations are able to support innovative, ‘out of the box’ research that may not attract mainstream funding.


Managed by Perpetual, the Ramaciotti Foundations were established in 1970 with a $6.7 million bequest. Since then, the charitable trusts have donated more than $47.5 million to biomedical research and this year’s $2.5 million worth of grants is the largest distribution in its history.


Got a story to share?

Got a news tip or article idea for Pro Bono News? Or perhaps you would like to write an article and join a growing community of sector leaders sharing their thoughts and analysis with Pro Bono News readers?

Get in touch at

Tags : Awards, Research, Science,


Get more stories like this


Write a Reply or Comment

Your email address will not be published. Required fields are marked *


The best of impact investing and corporate giving revealed

Maggie Coggan

Wednesday, 4th December 2019 at 8:56 am


Marilyn Jones

Monday, 21st October 2019 at 8:36 am

Setting Aussie kids up for success

Luke Michael

Wednesday, 5th June 2019 at 4:13 pm

Impact 25 winners revealed

Wendy Williams

Tuesday, 12th March 2019 at 8:49 am


How are Aussie charities helping in the bushfire crisis?

Luke Michael

Tuesday, 7th January 2020 at 3:21 pm

What impact will the bushfire crisis have on homelessness?

Luke Michael

Wednesday, 15th January 2020 at 4:28 pm

The rise (and scepticism) of Facebook fundraisers

Maggie Coggan

Thursday, 16th January 2020 at 8:49 am

What about the charities?

Maggie Coggan

Wednesday, 8th January 2020 at 1:26 pm

Subscribe to News
pba inverse logo
Subscribe Twitter Facebook

Get the social sector's most essential news coverage. Delivered free to your inbox every Tuesday and Thursday morning.

You have Successfully Subscribed!